India’s healthcare and pharmaceutical communications landscape is at a critical inflection point. As scientific innovation accelerates, the industry is moving beyond conventional messaging towards engagement models that are medically robust, experience-led, compliant, and demonstrably measurable. Yet, a longstanding gap persists – between agencies that deeply understand science and those that excel at large-scale experiential execution.
Addressing this unmet need, Havas Life Mumbai (the healthcare agency of Havas India) and Shobiz (Havas India’s experiential agency) have come together to deliver fully integrated, end-to-end experiential solutions for healthcare and pharma brands in India. The collaboration brings together Havas Life Mumbai’s deep expertise in health and medical communications with Shobiz’s proven strength in innovation-led experiential design and execution, creating a single, unified partner capable of bridging strategy and execution seamlessly. Together, the two agencies under Havas India aim to redefine how healthcare brands engage healthcare professionals (HCPs), patients,
and caregivers, through experiences that are scientifically credible, creatively compelling, fully compliant, and outcome driven.
The partnership will enable brands to leverage next-generation engagement solutions, including immersive VR, AR, MR simulations, AI-powered interactive tools, and data-driven engagement platforms, setting new benchmarks for impact and effectiveness across the industry.
Read more: Havas India Appoints Dorelle Kulkarni As Managing Director Of Havas Life Mumbai
Charles Houdoux, Global Chief Client Officer Havas Health, CEO APAC-LATAM said,
“By uniting the scientific rigor and healthcare leadership of Havas Life Mumbai, with the transformative power of experience design from Shobiz, we are redefining how the industry engages with healthcare professionals. This collaboration is not simply about communication or events — it is about building a new paradigm where knowledge,
emotion, and experience converge to accelerate the understanding and adoption of innovation. Together, we are shaping a more connected, more immersive, and ultimately more impactful future for healthcare engagement — one that drives better decisions, deeper trust, and improved patient outcomes.”
Rana Barua, Group CEO, Havas India, SEA & North Asia (Japan and South Korea) said,
“The collaboration between Havas Life Mumbai and Shobiz brings together two extraordinary powerhouses, one rooted in deep medical intelligence, the other in experiential innovation at scale. This partnership enables us to move beyond traditional engagement and create truly differentiated, more desirable experiences for the world of health & wellness. This is the future of experiential healthcare in India, and we are proud to be leading it.”
Commenting on the partnership, Dorelle Kulkarni, Managing Director, Havas Life Mumbai said,
“Healthcare brands today need far more than communication—they need experiences that simplify complex science, inspire action, and build long-term trust. Our partnership with Shobiz brings together deep medical intelligence with world-class experiential capability, allowing us to create transformative, insight-led engagements that are impactful and measurable. Together, we are setting a new standard for health experiences in India.”
Sameer Tobaccowala, CEO, Shobiz said,
“The future of healthcare engagement lies at the intersection of scientific credibility and immersive, thoughtfully curated experiences. By combining Shobiz’s legacy of delivering large-scale, technology- driven experiential solutions with Havas Life Mumbai’s deep understanding of the healthcare ecosystem, we are uniquely positioned to offer clients truly integrated and compliant engagement platforms that deliver tangible business outcomes and move
the industry forward.”
With this partnership, Havas Life Mumbai and Shobiz aim to not only elevate experiential engagement for healthcare and pharma brands but also shape the future of how medical science is communicated, experienced, and acted upon in India.
